From the Journals

Study finds sharp drop in opioid scripts among most specialties


 

What’s missing

Maya Hambright, MD, a family medicine physician in New York’s Hudson Valley, who has been working mainly in addiction in response to the opioid overdose crisis, observed that the drop in total prescribed volume of prescription painkillers does not necessarily translate into a reduction in use of opioids

“No one is taking fewer opioids,” Dr. Hambright told this news organization. “I can say that comfortably. They are just getting them from other sources.”

CDC data support Dr. Hambright’s view.

An estimated 100,306 people in the United States died of a drug overdose in the 12 months that ended in April 2021, an increase of 28.5% from the 78,056 deaths during the same period the year before, according to the CDC.

Dr. Hambright said more physicians need to be involved in prescribing medication-assisted treatment (MAT).

The federal government has in the past year loosened restrictions on a requirement, known as an X waiver. Certain clinicians have been exempted from training requirements, as explained in the frequently asked questions page on the Substance Abuse and Mental Health Services Administration website.

SAMHSA says legislation is required to eliminate the waiver. As of Dec. 30, 2021, more than half of the members of the U.S. House of Representatives were listed as sponsors of the Mainstreaming Addiction Treatment (MAT) Act (HR 1384), which would end the need for X waivers. The bill has the backing of 187 Democrats and 43 Republicans.

At this time, too many physicians shy away from offering MAT, Dr. Hambright said.

“People are still scared of it,” she said. “People don’t want to deal with addicts.”

But Dr. Hambright said it’s well worth the initial time invested in having the needed conversations with patients about MAT.

“Afterwards, it’s so straightforward. People feel better. They’re healthier. It’s amazing,” she said. “You’re changing lives.”

The research was supported by grants from the National Institutes of Health. Dr. Stein and coauthors reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Good news, bad news for buprenorphine in opioid use disorder
Federal Practitioner
Warn patients about illicit drugs doctored with fentanyl
Federal Practitioner
PT may lower risk of long-term opioid use after knee replacement
Federal Practitioner
Patients given NSAIDs over antiemetics for headaches spend less time in the ED
Federal Practitioner
U.S. overdose deaths hit an all-time high
Federal Practitioner
Neurologist guilty of overprescribing thousands of doses of painkillers
Federal Practitioner
Short-acting opioids needed for withdrawal in U.S. hospitals, say experts
Federal Practitioner
Multimodal Pain Management With Adductor Canal Block Decreases Opioid Consumption Following Total Knee Arthroplasty
Federal Practitioner
Califf plans work on opioids, accelerated approvals on return to FDA
Federal Practitioner
AAN updates treatment guidance on painful diabetic neuropathy
Federal Practitioner